
Medicare’s report card is in
Humana just got a pretty useful piece of paper from CMS: improved Star Ratings for its 2027 Medicare Advantage plans. The headline number is the juicy part — 95% of Humana’s Medicare Advantage members are now in plans rated 4 stars or better.
For a company like Humana, this isn’t just bragging rights for the investor deck. In Medicare Advantage, Star Ratings can influence everything from bonus payments to how easy it is to attract new members. Think of it like Yelp, except the stakes are your health coverage and a very large pile of cash.
Why investors should care
A better rating can be a tailwind for:
- enrollment growth, because higher-rated plans are easier to market
- reimbursement, since CMS rewards strong performance
- confidence in the business, especially after a stretch where the Medicare crowd has been under a microscope
That said, this is still one piece of the puzzle. Ratings help, but they don’t magically fix medical cost trends, utilization pressure, or the eternal chaos of managing a giant health plan business.
Big picture
Still, this is the kind of update Wall Street likes to see: concrete, measurable, and not obviously a head-scratcher. In a sector where bad news often arrives with a side of regulatory drama, a CMS upgrade is about as close as you get to a corporate gold star.